Regadenoson
Active substance: Regadenoson
INJECTION, SOLUTION · REGADENOSON .08 mg/mL
United StatesActive
Marketing holder: Apotex Corp.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- REGADENOSON · .08 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4634-7149-8996-5ee26b4ebbf6,01a1208c-e097-7639-8a19-de260a8e16c1,01a1208d-39ea-7945-8406-666a7b7ae13f,01a1208d-af97-7e36-a0b2-3a550b6ad59a,01a1208f-1460-7a68-9862-a8b903ac7afe;count=16 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 60505-6116
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 60505-6116 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 60505-6116 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 60505-6116 · Verified 2026-10-09 · open in source